Delivery Order SPE2DB25D3002-SPE2DB25FLQTT
Award Date
6/4/25
Potential Completion Date
6/5/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,705.97, is for the delivery of 120 tablets of the prescription drug Mesalamine delayed-release 1.2 gram. The contract is a firm-fixed price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 180 capsules of 400 mg Mesalamine DR (delayed release) with a ceiling value of $5,439.88. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine 1.2G 120S, a pharmaceutical product, with a ceiling value of $4,118.76 and a period of performance through May 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
The U.S. Defense Logistics Agency (DLA) awarded a $5,180.22 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,562,817,232 units of the drug Mesalamine DR 1.2 GM Tablet 120S. The contract has an ultimate completion date of November 15, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $2,098.63 and is for the delivery of 120 units of the pharmaceutical product Mesalamine 1.2 grams. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,178.58, is for the delivery of 120 tablets of the pharmaceutical product Mesalamine DR 1.2 GM. The contract has a completion date of February 26, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.47 firm-fixed-price contract is for the delivery of 180 units of 800 mg delayed-release mesalamine tablets, a medication used to treat gastrointestinal conditions. The contract has an ultimate completion date of October 20, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,494.65 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567696122 MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product, with an ultimate completion date of March 27, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a $3,654.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,231,508 units of the medication Mesalamine DR 1.2 GM Tablet 120S. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,147.79, is for the delivery of Mesalamine delayed-release 1.2 gram tablets in quantities of 120 tablets per bottle. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the...